Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials

MLA

Noth, I.(Imre), et al. Cardiovascular Safety of Nintedanib in Subgroups by Cardiovascular Risk at Baseline in the TOMORROW and INPULSIS Trials. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1126405665&authtype=sso&custid=ns315887.

APA

Noth, I. (Imre), Wijsenbeek-Lourens, M. S. (Marlies), Kolb, M. (Martin), Bonella, F. (Francesco), Moros, L. (Lizette), Wachtlin, D. (Daniel), & Corte, T. J. (Tamera J. . (2019). Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials.

Chicago

Noth, I. (Imre), M.S. (Marlies) Wijsenbeek-Lourens, M. (Martin) Kolb, F. (Francesco) Bonella, L. (Lizette) Moros, D. (Daniel) Wachtlin, and T.J. (Tamera J.) Corte. 2019. “Cardiovascular Safety of Nintedanib in Subgroups by Cardiovascular Risk at Baseline in the TOMORROW and INPULSIS Trials.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1126405665&authtype=sso&custid=ns315887.